1. ScholarBank@NUS

Chandra Shekhar Verma

rp08572

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Chandra Shekhar Verma
Variants
Verma, C.S.
Verma, Chandra Shekhar
Chandra Verma
Verma Chandra
Verma, C.
Verma, Chandra
 
Main Affiliation
 
Faculty
 
Email
dbscsv@nus.edu.sg
 

Publications

Results 101-120 of 123 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
1012008Stability of the core domain of p53: Insights from computer simulationsMadhumalar, A; Smith, D.J; Verma, C 
10231-Aug-2012Stapled BH3 Peptides against MCL-1: Mechanism and Design Using Atomistic SimulationsJoseph, T.L.; Lane, D.P.; Verma, C.S. 
1032018Stapled peptides as a new technology to investigate protein-protein interactions in human plateletsIegre, J.; Ahmed, N.S.; Gaynord, J.S.; Wu, Y.; Herlihy, K.M.; Tan, Y.S.; Lopes-Pires, M.E.; Jha, R.; Lau, Y.H.; Sore, H.F.; Verma, C. ; O'Donovan, D.H.; Pugh, N.; Spring, D.R.
10415-Mar-2013Stapled peptides with improved potency and specificity that activate p53Brown, C.J.; Quah, S.T.; Jong, J.; Goh, A.M.; Chiam, P.C.; Khoo, K.H.; Choong, M.L.; Lee, M.A.; Yurlova, L.; Zolghadr, K.; Joseph, T.L.; Verma, C.S. ; Lane, D.P.
1058-Dec-2010Structural and functional analysis of phosphothreonine-dependent FHA domain interactionsPennell, S.; Westcott, S.; Ortiz-Lombardía, M.; Patel, D.; Li, J.; Nott, T.J.; Mohammed, D.; Buxton, R.S.; Yaffe, M.B.; Verma, C. ; Smerdon, S.J.
1061-Dec-2006Structural Basis of the Sulphate Starvation Response in E. coli: Crystal Structure and Mutational Analysis of the Cofactor-binding Domain of the Cbl Transcriptional RegulatorStec, E.; Witkowska-Zimny, M.; Hryniewicz, M.M.; Neumann, P.; Wilkinson, A.J.; Brzozowski, A.M.; Verma, C.S. ; Zaim, J.; Wysocki, S.; D. Bujacz, G.
1072019Structural insights reveal a recognition feature for tailoring hydrocarbon stapled-peptides against the eukaryotic translation initiation factor 4E proteinLama, D.; Liberatore, A.-M.; Frosi, Y.; Nakhle, J.; Tsomaia, N.; Bashir, T.; Lane, D.P.; Brown, C.J.; Verma, C.S. ; Auvin, S.
1082014Structure of a stapled peptide antagonist bound to nutlin-resistant Mdm2Chee S.M.Q.; Wongsantichon J.; Soo Tng Q.; Robinson R. ; Joseph T.L.; Verma C. ; Lane D.P. ; Brown C.J.; Ghadessy F.J.
109Feb-2012Subunit F modulates ATP binding and migration in the nucleotide-binding subunit B of the A 1A O ATP synthase of Methanosarcina mazei Gö1Raghunathan, D.; Gayen, S.; Kumar, A.; Hunke, C.; Grüber, G.; Verma, C.S. 
1022-May-2011Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: An in silico based mechanismFuentes, G.; Scaltriti, M.; Baselga, J.; Verma, C.S. 
113-Feb-2014Synthetic multivalent antifungal peptides effective against fungiLakshminarayanan, R. ; Liu, S. ; Li, J.; Nandhakumar, M.; Aung, T.T.; Goh, E.; Chang, J.Y.T.; Saraswathi, P.; Tang, C.; Safie, S.R.B.; Lin, L.Y.; Riezman, H.; Lei, Z.; Verma, C.S. ; Beuerman, R.W.
12Dec-2011Systematic mutational analysis of an ubiquitin ligase (MDM2)-binding peptide: Computational studiesLiu, Y.; Lane, D.P.; Verma, C.S. 
1329-Apr-2020Targeting codon 158 p53-mutant cancers via the induction of p53 acetylationKong, Li Ren ; Ong, Richard Weijie; Tan, Tuan Zea ; Salleh, Nur Afiqah Binte Mohamed ; Thangavelu, Matan; Chan, Jane Vin; Koh, Lie Yong Judice; Periyasamy, Giridharan; Lau, Jieying Amelia ; Le, Thi Bich Uyen; Wang, Lingzhi ; Lee, Miyoung; Kannan, Srinivasaraghavan; Verma, Chandra S ; Lim, Chwee Ming ; Chng, Wee Joo ; Lane, David P ; Venkitaraman, Ashok ; Hung, Huynh The; Cheok, Chit Fang ; Goh, Boon Cher 
142017Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approachesKaan H.Y.K.; Sim A.Y.L.; Tan S.K.J.; Verma C. ; Song H. 
152006The 1.8 Å resolution structure of hydroxycinnamoyl-coenzyme a hydratase-lyase (HCHL) from Pseudomonas fluorescens, an enzyme that catalyses the transformation of feruloyl-coenzyme A to vanillinLeonard, P.M; Brzozowski, A.M; Lebedev, A; Marshall, C.M; Smith, D.J; Verma, C.S ; Walton, N.J; Grogan, G
162019The dual interactions of p53 with MDM2 and p300: Implications for the design of MDM2 inhibitorsKannan, S.; Partridge, A.W.; Lane, D.P.; Verma, C.S. 
1713-Oct-2006The last 10 amino acid residues beyond the hydrophobic motif are critical for the catalytic competence and function of protein kinase CαSui, S.Y.; Zhu, Y.; Smith, D.; Verma, C. ; Wee, G.L.; Bee, J.T. ; Qiu, T.L.; Nam, S.C.; Cai, M.; Zhu, Y.-N.; Zhou, S.-F. ; Tan, S.-L.; Duan, W.
181-Mar-2021The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolveBudhraja, Anshul; Pandey, Sakshi; Kannan, Srinivasaraghavan; Verma, Chandra S. ; Venkatraman, Prasanna
1919-Jan-2023The Singapore National Precision Medicine StrategyWong E; Bertin N; Hebrard M; Tirado-Magallanes R ; Bellis C; Lim WK ; Chua CY ; Tong PML; Chua R ; Mak K; Lim TM ; Cheong WY; Thien KE; Goh KT; Chai JF ; Lee J ; Sung JJ; Wong TY ; Chin CWL ; Gluckman PD ; Goh LL; Ban KHK ; Tan TW ; Sim X ; Cheng CY ; Davila S ; Karnani N ; Leong KP; Liu J ; Prabhakar S; Maurer-Stroh S ; Verma CS ; Krishnaswamy P; Goh RSM ; Chia I; Ho C; Low D; Virabhak S ; Yong J ; Zheng W ; Seow SW ; Seck YK; Koh M; Chambers JC; Tai ES ; Tan P. ; SG10K_Health Consortium
20Apr-2012Theory and simulation: Complexity and emergenceFernandez-Recio, J.; Verma, C.